3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Thoracic
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
22
Lung Neoplasms
10
Small Cell Lung Carcinoma
6
Thymoma
5
Carcinoma, Renal Cell
4
Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Gastrointestinal Stromal Tumors
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Somatostatinoma
1
Recurrence
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Lymphoma
1
Interventions
Docetaxel
8
pembrolizumab
7
Pemetrexed
5
Carboplatin
5
Erlotinib Hydrochloride
4
toripalimab
3
rociletinib
3
fludarabine
3
Radiosurgery
3
Paclitaxel
3
Oxaliplatin
3
Nivolumab
3
Gemcitabine
3
Etoposide
3
Cyclophosphamide
3
Cisplatin
3
Bevacizumab
3
lorlatinib
2
atezolizumab
2
Vinorelbine
2
Topotecan
2
Radiotherapy
2
Platinum
2
Itraconazole
2
Irinotecan
2
Interleukin-2
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
vinflunine
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Sunitinib
×
Thoracic
×
Clear all
NCT02623127
2019-01-23
KOSMIC
Seoul National University Hospital
Phase 2
Completed
25 enrolled